What Is Borderline E C G Understanding Ambiguous Heart Rhythm Findings

Published

Table of Contents

Borderline electrocardiogram (ECG) findings represent a diagnostic gray area where subtle deviations from normal heart rhythms defy clear classification, posing challenges for clinicians in risk assessment and treatment planning. Unlike definitive abnormalities such as ST-segment elevation myocardial infarction or complete heart block, borderline ECGs—such as mild ST-segment shifts, nonspecific T-wave changes, or borderline QRS voltages—lack consensus criteria, requiring a nuanced approach to interpretation. These ambiguous patterns often reflect early-stage cardiac conditions, benign variants, or technical artifacts, yet their prognostic significance demands rigorous evaluation to prevent missed diagnoses or unnecessary interventions.

The clinical relevance of borderline ECGs extends beyond mere ambiguity; they serve as critical markers in cardiovascular risk stratification, particularly in asymptomatic patients or those with preexisting comorbidities. Studies indicate that even minor deviations—such as borderline ST-segment depression or nonspecific T-wave inversions—may correlate with increased long-term risks of ischemic events, arrhythmias, or sudden cardiac death, necessitating tailored diagnostic workflows. This exploration examines the definitions, differential diagnoses, and diagnostic strategies for borderline ECG findings, integrating evidence-based guidelines and emerging technologies to clarify their clinical implications.

what is borderline ecg

Definition and Clinical Context of Borderline ECG Findings

Borderline electrocardiogram (ECG) findings represent a diagnostic gray zone where ECG abnormalities do not meet the established criteria for definitive pathological conditions (e.g., acute ischemia, left ventricular hypertrophy, or arrhythmias) but exhibit subtle deviations from normalcy. These findings challenge clinicians to differentiate between benign variants, early-stage pathology, or non-specific changes that may warrant further investigation. The ambiguity of borderline ECGs stems from their overlap with normal physiological variability, technical artifacts, or early-stage cardiac dysfunction, necessitating a structured approach to risk assessment and diagnostic workup.

The clinical significance of borderline ECG findings lies in their potential to precede overt cardiovascular events, such as myocardial infarction, heart failure, or sudden cardiac death. Unlike definitive abnormalities, which trigger immediate intervention (e.g., thrombolysis for ST-elevation myocardial infarction), borderline results require a nuanced evaluation of patient history, symptoms, and additional diagnostic tools (e.g., troponin assays, echocardiography, or stress testing). Misinterpretation of these findings can lead to either unnecessary stress for patients or delayed recognition of emerging pathology.

Distinguishing Borderline ECG Findings from Definitive Abnormalities

Borderline ECG patterns lack the specificity and reproducibility of clear-cut abnormalities, which are defined by well-validated criteria (e.g., ≥1 mm ST-segment elevation in contiguous leads for acute myocardial infarction or Sokolow-Lyon voltage criteria for left ventricular hypertrophy). The ambiguity arises from:
  • Subthreshold deviations: ECG parameters (e.g., ST-segment depression, T-wave inversion, or QRS duration) that fall below diagnostic thresholds but exceed normal ranges.
  • Interobserver variability: Subjective interpretation of waveforms, particularly in leads with low signal-to-noise ratios or overlapping syndromes (e.g., early repolarization vs. ischemia).
  • Dynamic changes: Findings that fluctuate with patient positioning, respiration, or autonomic tone (e.g., nonspecific ST-T wave changes in young athletes).

    • Key differences between borderline and definitive ECG abnormalities are summarized below:

    Feature Borderline ECG Findings Definitive ECG Abnormalities
    ST-Segment Changes
    • Subendocardial depression: <0.5 mm in multiple leads (e.g., V4–V6), often with concave morphology.
    • Upsloping ST depression: Gradual return to baseline, lacking the "sagging" pattern of ischemia.
    • Early repolarization: J-point elevation (<0.1 mV) with concave ST elevation in precordial leads, typically in young individuals.
    • Ischemic ST depression: ≥0.5 mm horizontal or downsloping in contiguous leads, often with reciprocal changes.
    • ST-elevation myocardial infarction (STEMI): ≥1 mm elevation in ≥2 contiguous leads with reciprocal depression.
    T-Wave Abnormalities
    • Nonspecific T-wave flattening or inversion: Asymmetric, shallow inversions in leads without QRS changes (e.g., V1–V3 in young adults).
    • Hyperacute T-waves: Symmetric, peaked T-waves (<0.5 mV) without ST elevation, often seen in early reperfusion.
    • Wellens’ syndrome: Deep, symmetric T-wave inversions in V1–V3 with normal R-wave progression, indicating critical LAD stenosis.
    • Hyperacute T-waves: ≥0.5 mV with ST elevation, indicating acute ischemia.
    QRS Complex
    • Borderline left ventricular hypertrophy (LVH): Sokolow-Lyon index (SV1 + RV5/6) between 35–45 mm without strain pattern.
    • Incomplete bundle branch block: QRS duration 100–120 ms with incomplete RSR’ in V1 or broad notched S-waves in V5–V6.
    • Complete LVH: Sokolow-Lyon index ≥45 mm with repolarization changes (e.g., ST depression, T-wave inversion).
    • Complete bundle branch block: QRS ≥120 ms with typical RSR’ in V1 (RBBB) or broad monophasic R-waves in V5–V6 (LBBB).
    Clinical Implication
    "Borderline findings mandate risk stratification with clinical correlation, serial ECGs, and adjunctive testing (e.g., troponin, echocardiography). Prognostic value depends on patient-specific factors (e.g., symptoms, comorbidities, family history)."
    "Definitive abnormalities trigger immediate intervention (e.g., reperfusion therapy for STEMI) or chronic management (e.g., beta-blockers for LVH)."
    The diagnostic challenge of borderline ECGs is compounded by their low positive predictive value (PPV) in isolation. For example, nonspecific ST-T wave changes have a PPV of <20% for acute coronary syndrome (ACS) in low-risk patients (Antman et al., 2000), whereas definitive ST-segment elevation in STEMI carries a PPV >90%. However, borderline findings may still reflect subclinical cardiac stress, such as:
  • Microvascular dysfunction: Nonspecific T-wave inversions in patients with diabetes or hypertension.
  • Early repolarization syndrome: J-point elevation associated with a 2–3× increased risk of ventricular arrhythmias in high-risk subgroups (Haïssaguerre et al., 2013).
  • Subclinical ischemia: ST depression <0.5 mm in patients with stable angina, where exercise testing may unmask inducible ischemia.

    • Role of Borderline ECGs in Cardiovascular Risk Stratification

    Borderline ECG findings serve as modifiers of cardiovascular risk, particularly in asymptomatic individuals or those with intermediate pretest probability. Their prognostic value is context-dependent and often integrated into multifactorial risk scores (e.g., Framingham, SCORE2, or ACC/AHA ASCVD risk calculator). Key studies highlight their utility in specific populations:

    1. Nonspecific ST-T Wave Abnormalities

  • Prognostic relevance: In the Framingham Heart Study, nonspecific T-wave inversions in leads V1–V3 were associated with a 2.5× higher risk of coronary heart disease (CHD) over 10 years, independent of traditional risk factors (Kannel et al., 1989).
  • Mechanism: Likely reflects subendocardial ischemia or repolarization heterogeneity due to myocardial fibrosis or infiltrative diseases (e.g., amyloidosis).
  • Clinical actionability: European Society of Cardiology (ESC) guidelines recommend coronary angiography in patients with borderline T-wave changes plus symptoms or high-risk features (e.g., diabetes, family history of premature CHD) (Piepoli et al., 2021).

    • 2. Borderline ST-Segment Depression

  • Prognostic relevance: In the Physicians’ Health Study, ST depression <0.5 mm during exercise testing was linked to a 1.8× increased risk of myocardial infarction (MI) or cardiovascular death over 5 years (Lee et al., 1996).
  • Differential diagnosis: Must exclude early repolarization (concave ST elevation) or digitalis effect (scooped ST depression with T-wave inversion).
  • Guideline recommendations: The ACC/AHA guidelines on stable ischemic heart disease classify borderline ST depression as a class IIb indication for stress testing in intermediate-risk patients (Fihn et al., 2021).

    • 3. Borderline Left Ventricular Hypertrophy (LVH)

  • Prognostic relevance: The ARIC (Atherosclerosis Risk in Communities) study demonstrated that borderline LVH (Sokolow-Lyon index 35–45 mm) conferred a 1.5× higher risk of heart failure and a 1.3× higher risk of CHD compared to normal ECGs (Liao et al., 1995).
    • -

    Common Borderline ECG Patterns and Their Underlying Causes

    Borderline ECG findings represent subtle deviations from normal tracings that may lack definitive diagnostic significance but warrant careful evaluation. These patterns often challenge clinicians due to their overlap with benign variants, early-stage pathology, or technical artifacts. Accurate interpretation requires systematic analysis of waveform morphology, measurement thresholds, and clinical correlation. This section examines the most frequently encountered borderline ECG patterns—ST-segment deviations, T-wave abnormalities, mild voltage criteria, and PR interval variations—while distinguishing them from artifacts and delineating their potential etiologies.

    Borderline ST-Segment Depression or Elevation (<1 mm)

    ST-segment deviations of <1 mm are commonly observed in clinical practice and may reflect early repolarization, benign variants, or subtle ischemic changes. Key visual cues for differentiation include:
  • Early repolarization (ER): Concave ST elevation (J-point elevation) in precordial leads (V1–V4), often with prominent R waves and upright T waves. Typically resolves by lead V6.
  • Subendocardial ischemia: Downsloping or flat ST depression, often associated with reciprocal changes in other leads (e.g., ST elevation in aVL with inferior ischemia).
  • Technical artifacts: Baseline wander (respiratory or electrode motion), lead misplacement (e.g., inverted lead II), or poor skin-electrode contact (producing irregular ST segments).

    • Measurement thresholds for distinction:

  • ST elevation ≥1 mm in contiguous leads (excluding V1–V3) suggests acute ischemia or pericarditis.
  • ST depression ≥0.5 mm in contiguous leads (excluding V1–V2) raises suspicion for ischemia, though <1 mm may be nonspecific.

    • Potential underlying causes:

    • Benign variants:
    • Early repolarization syndrome (common in young males, athletes).
    • Normal variant ST elevation (e.g., in leads III/aVF).
    • Early ischemic shifts:
    • Subendocardial ischemia (e.g., coronary artery disease, vasospasm).
    • Microvascular dysfunction (e.g., syndrome X, diabetes mellitus).
    • Electrolyte imbalances:
    • Hypokalemia (U-wave prominence, flattened T waves).
    • Hyperkalemia (peaked T waves, prolonged PR interval).
    • Early-stage cardiac conditions:
    • Myocarditis (diffuse ST elevation with PR depression).
    • Hypertrophic cardiomyopathy (mild ST elevation in lateral leads).
    • Technical/non-cardiac causes:
    • Poor electrode contact (noisy baseline, irregular ST contours).
    • Lead misplacement (e.g., inverted lead II simulating ST depression).
    Differentiating borderline ST-T changes requires integrating:
    1. Waveform morphology (concave vs. downsloping ST, T-wave symmetry).
    2. Lead distribution (contiguous vs. isolated changes).
    3. Clinical context (symptoms, risk factors, prior ECGs).
    Benign early repolarization typically shows <1 mm ST elevation with upright T waves, while ischemic patterns often involve horizontal/downsloping ST depression with reciprocal changes.

    Nonspecific T-Wave Inversions or Flattening

    T-wave abnormalities, including flattening or inversions <2 mm in depth, are frequently encountered and may indicate early repolarization, ischemia, or non-ischemic cardiomyopathies. Key distinguishing features include:
  • Early repolarization: Upright T waves with ST elevation (V1–V4), often in young individuals.
  • Ischemic T-wave inversions: Typically deeper (>2 mm) and associated with ST depression or Q waves. Borderline inversions (<2 mm) may occur in:
  • Subendocardial ischemia (e.g., balanced ischemia in multivessel disease).
  • Ventricular hypertrophy (strain pattern, e.g., lateral leads in hypertension).
  • Technical errors: Lead reversal (e.g., inverted lead III/aVF), poor R-wave progression (pseudo-inversions), or baseline drift.

    • Measurement thresholds for distinction:

  • T-wave inversions ≥2 mm in ≥2 contiguous leads suggest ischemia or cardiomyopathy.
  • Flattened T waves (<1 mm amplitude) may reflect hypokalemia, early repolarization, or digitalis effect.

    • Potential underlying causes:

    • Benign variants:
    • Early repolarization (T waves remain upright in most leads).
    • Normal aging (generalized T-wave flattening).
    • Ischemic or hypertrophic changes:
    • Mild left ventricular hypertrophy (LVH) with strain (T-wave inversions in V5–V6, I, aVL).
    • Coronary artery disease (subendocardial ischemia, e.g., in right coronary artery dominance).
    • Electrolyte and metabolic disturbances:
    • Hypokalemia (U waves, flattened T waves).
    • Hyperkalemia (peaked T waves progressing to inversion).
    • Hypothyroidism (prolonged QT, low-voltage QRS).
    • Infiltrative or inflammatory conditions:
    • Amyloidosis (low-voltage QRS with pseudo-infarction patterns).
    • Myocarditis (diffuse T-wave inversions, PR depression).
    • Drug effects:
    • Digitalis toxicity (scooped ST depression, T-wave inversions).
    • Tricyclic antidepressants (QRS widening, T-wave flattening).

    Mild QRS Voltage Criteria for Hypertrophy

    Borderline QRS voltage criteria for left ventricular hypertrophy (LVH) or right ventricular hypertrophy (RVH) often fall within indeterminate ranges (e.g., Sokolow-Lyon index 30–35 mm, R-wave progression V1–V6 <5 mm transition). These findings may reflect:
  • Early-stage hypertrophy: Asymptomatic athletes, controlled hypertension, or mild valvulopathy.
  • Technical limitations: Obesity, emphysema (reduced voltage), or lead misplacement (e.g., inverted lead I).
  • Conduction delays: Bundle branch blocks (BBB) may mimic or mask voltage criteria.

    • Measurement thresholds for distinction:

  • LVH (Sokolow-Lyon): R in V5/V6 + S in V1 ≥35 mm (borderline: 30–35 mm).
  • RVH: R in V1 ≥7 mm (borderline: 5–7 mm) with R > S in V1.
  • Low voltage: All limb leads <5 mm, precordial leads <10 mm (excluding V1).

    • Potential underlying causes:

    • Physiologic adaptations:
    • Athletic heart syndrome (increased QRS voltage with normal cardiac function).
    • Obesity or chronic lung disease (reduced voltage due to increased thoracic impedance).
    • Early-stage cardiac disease:
    • Hypertension (mild LVH with strain pattern).
    • Valvular heart disease (aortic stenosis, mitral regurgitation).
    • Hypertrophic cardiomyopathy (asymmetric septal hypertrophy).
    • Technical and non-cardiac factors:
    • Poor electrode contact (reduced voltage in all leads).
    • Lead reversal (e.g., inverted lead I simulating low voltage).
    • Pericardial effusion or pulmonary hypertension (low-voltage QRS).
    • Conduction abnormalities:
    • Incomplete BBB (mild QRS widening, delayed intrinsicoid deflection).
    • Intraventricular conduction delay (prolonged QRS <120 ms).

    Borderline PR Interval Prolongation or Shortening

    PR interval measurements between 160–200 ms (prolonged) or <120 ms (shortened) may indicate early conduction system disease, electrolyte imbalances, or technical artifacts. Key differentiating features include:
  • First-degree AV block: Prolonged PR interval (>200 ms) with consistent conduction.
  • Wenckebach phenomenon: Progressive PR prolongation with dropped QRS (Mobitz type I).
  • Short PR interval: May reflect Lown-Ganong-Levine (LGL) syndrome or WPW syndrome (delta wave in pre-excitation).
  • Technical errors: Improper lead placement (e.g., lead II axis deviation), baseline drift, or atrial fibrillation with irregular PR intervals.

    • Measurement thresholds for distinction:

  • Prolonged PR: 160–200 ms (borderline); >200 ms (first-degree block).
  • Short PR: <120

    • what is borderline ecg - Ilustrasi 2

    Diagnostic Workflow for Evaluating Borderline ECG Findings

    Borderline ECG findings present a diagnostic challenge due to their ambiguous nature, often straddling the line between normal variants and pathological abnormalities. A systematic approach is essential to minimize misinterpretation, reduce unnecessary testing, and ensure timely identification of clinically significant conditions. This workflow integrates immediate technical validation, clinical correlation, and targeted adjunctive diagnostics to refine diagnostic accuracy. The process emphasizes structured decision-making, leveraging ECG patterns, patient history, and evidence-based protocols to guide further evaluation.

    Step-by-Step Procedural Outline for Clinicians

    Immediate Technical Validation
    The first priority when encountering a borderline ECG is to rule out transient or technical artifacts that could distort interpretation. ECG tracings may reflect lead misplacement, poor skin contact, or patient movement, particularly in emergency settings or portable recordings. A repeat ECG within 15–30 minutes under standardized conditions (e.g., proper electrode placement, patient at rest, and using the same machine calibration) is critical. If the abnormality persists, proceed to clinical correlation.

    Integration of Clinical History and Risk Stratification
    Borderline ECG findings must be evaluated in the context of the patient’s symptoms, comorbidities, and cardiovascular risk factors. Key historical elements include:

  • Symptoms: Chest discomfort, dyspnea, syncope, or palpitations may suggest ischemic or arrhythmic etiology.
  • Risk Factors: Diabetes, hypertension, hyperlipidemia, smoking, or family history of coronary artery disease (CAD) elevate suspicion for ischemic changes.
  • Medications: Antiarrhythmics (e.g., digoxin), electrolytes (e.g., hypokalemia), or psychotropics may induce reversible ECG patterns.
  • Concurrent Conditions: Pulmonary embolism, aortic stenosis, or hypertrophic cardiomyopathy can mimic or exacerbate borderline patterns.

    • Adjunctive Diagnostic Testing Based on ECG Patterns
    The choice of supplementary tests depends on the specific borderline finding and clinical suspicion. Below are evidence-based recommendations for common scenarios:

    • Borderline ST-segment depression or elevation
      • Silent ischemia evaluation: Troponin levels (high-sensitivity troponin I/T) to assess myocardial necrosis, followed by stress testing (exercise or pharmacologic) or coronary angiography if high pre-test probability exists.
      • Early repolarization syndrome: Compare with prior ECGs; evaluate for family history of sudden cardiac death or ventricular arrhythmias. Consider signal-averaged ECG or genetic testing if clinical suspicion is high.
      • Brugada syndrome: Look for coved ST elevation in V1–V3; perform flecainide challenge if diagnostic uncertainty persists.
    • Nonspecific T-wave abnormalities (flattened/inverted)
      • Electrolyte imbalances: Check serum potassium, magnesium, and calcium levels. Correct abnormalities and reassess ECG.
      • Right ventricular strain: Evaluate for pulmonary hypertension or cor pulmonale via echocardiogram or right-heart catheterization if clinically indicated.
      • Myocardial ischemia/infarction: Troponin levels and echocardiogram to assess wall motion abnormalities or regional dysfunction.
    • QTc prolongation (borderline ≥450 ms in males/≥470 ms in females)
      • Drug-induced: Review medication list (e.g., antipsychotics, macrolides, fluoroquinolones). Discontinue offending agents if possible.
      • Congenital long QT syndrome: Obtain genetic testing (e.g., KCNQ1, KCNH2 mutations) and consider implantable cardioverter-defibrillator (ICD) if high-risk variants are identified.
      • Bradycardia: Assess for sinus node dysfunction or AV block; consider Holter monitoring if symptomatic.
    • Atrial or ventricular premature beats (frequent or multiform)
      • Arrhythmogenic substrate: Holter or event monitor (24–48 hours) to quantify burden and assess for non-sustained ventricular tachycardia (NSVT).
      • Structural heart disease: Echocardiogram to evaluate for cardiomyopathy or valvular abnormalities.
      • Autonomic dysfunction: Tilt-table testing if neurally mediated syncope is suspected.

    Decision-Tree Flowchart for Borderline ECG Patterns

    The following structured approach integrates ECG findings with clinical context to guide further evaluation. Use this as a reference for rapid decision-making:
    Borderline ECG Finding Clinical Context Recommended Next Steps High-Risk Red Flags
    ST depression in V4–V6 (1–2 mm, horizontal/downsloping) Patient with angina or risk factors for CAD; no prior ECG for comparison.
    1. Repeat ECG in 15–30 minutes.
    2. Troponin I/T + high-sensitivity CRP.
    3. Stress test (exercise or dobutamine) if intermediate risk.
    4. Coronary angiography if high-risk features (e.g., dynamic ST changes, troponin elevation).
    • Dynamic ST changes with symptoms.
    • New LBBB or RBBB.
    • Family history of sudden death.
    Nonspecific T-wave flattening/inversion in leads II/III/aVF Patient with COPD, pulmonary embolism, or electrolyte derangement.
    1. Check serum K+, Mg2+, and Ca2+.
    2. Echocardiogram to assess RV strain or pulmonary hypertension.
    3. V/Q scan or CTA if PE suspected.
    • Hypotension or right heart failure signs.
    • New-onset AF or RBBB.
    QTc 460–480 ms (males) or 480–500 ms (females) Patient on QT-prolonging medications or with syncope.
    1. Discontinue offending drugs if possible.
    2. Repeat ECG after correction of electrolytes.
    3. Genetic testing for LQTS if congenital suspected.
    4. ICD evaluation if high-risk genotype or family history of SCD.
    • Torsades de pointes on prior ECGs.
    • Family history of LQTS or unexplained death.
    Atrial fibrillation with borderline heart rate (60–100 bpm) Asymptomatic patient with no structural heart disease.
    1. Holter monitor for paroxysmal AF burden.
    2. Transthoracic echocardiogram to assess LA size and LV function.
    3. Consider CHA2DS2-VASc score for stroke risk.
    • Prior stroke or TIA.
    • LV hypertrophy or heart failure.

    Documentation of Borderline Findings in Medical Records

    Accurate and unambiguous documentation is critical to prevent misinterpretation and ensure continuity of care. Below are structured guidelines for reporting borderline ECG findings, including suggested phrasing and key elements to include:

    Key Principles for Documentation

  • Avoid absolute terms: Use qualifiers such as *"border

    • Borderline ECG Findings in Specific Patient Populations

    Borderline ECG findings exhibit distinct manifestations across patient populations due to physiological adaptations, comorbidities, and age-related changes. In athletes, early repolarization variants may mimic acute myocardial infarction, while elderly patients often present with subtle conduction delays that could indicate subclinical cardiomyopathies. Pediatric and adolescent patients may demonstrate borderline QRS voltages due to normal developmental variations, complicating differentiation from congenital heart disease. Clinical context—such as symptom presence, risk factors, and pretest probability—plays a pivotal role in guiding further diagnostic evaluation. Management approaches differ significantly between asymptomatic and symptomatic patients, with thresholds for additional testing (e.g., stress testing, cardiac MRI) varying based on population-specific risk stratification.

    Manifestations in Athletes with Early Repolarization Variants

    Athletes, particularly those engaged in endurance sports, frequently exhibit early repolarization (ER) patterns characterized by ST-segment elevation in the inferior and lateral leads (I, II, aVL, V4–V6) with concave morphology. These findings are typically benign but can mimic acute myocardial infarction (AMI), leading to misdiagnosis and unnecessary interventions.

    Key Features:

  • ST-segment elevation (≥1 mm in ≥2 contiguous leads) with concave upsloping morphology, often maximal in V4–V6.
  • Absence of reciprocal ST depression or dynamic changes.
  • J-wave prominence (Osborn waves) in leads with high voltage, particularly during exercise or in cold environments.
  • T-wave inversion in V1–V3 (normal for athletes) or lateral leads (may indicate underlying pathology).

    • Clinical Context and Differentiation:

  • Asymptomatic athletes with ER variants and normal troponin levels require no further action unless symptoms (e.g., chest pain, syncope) develop.
  • Symptomatic athletes (e.g., exertional chest discomfort) warrant stress testing (exercise ECG or cardiac MRI) to rule out coronary artery disease (CAD) or hypertrophic cardiomyopathy (HCM).
  • Case Example:
    • A 22-year-old competitive swimmer presents with 1.5 mm ST elevation in V4–V6 during a routine pre-participation ECG. The pattern is concave, with no reciprocal changes or dynamic ST shifts. Given the absence of symptoms, a normal cardiac MRI and negative family history of sudden cardiac death (SCD), the findings are attributed to athlete’s heart. However, if the patient later reports exertional syncope, further evaluation for arrhythmogenic right ventricular cardiomyopathy (ARVC) or long QT syndrome is warranted.
    Elderly patients frequently demonstrate borderline conduction abnormalities, including first-degree AV block, bundle branch blocks (BBB), and intraventricular conduction delays (IVCD). These findings may reflect age-related fibrosis, autonomic dysfunction, or subclinical cardiomyopathies, complicating differentiation from clinically significant conduction disease.

    Common Patterns and Underlying Causes:

  • First-degree AV block (PR interval ≥200 ms) is common in the elderly due to fibrosis of the AV node or autonomic imbalance.
  • Left bundle branch block (LBBB) or right bundle branch block (RBBB) may indicate ischemic heart disease, hypertension, or infiltrative cardiomyopathies (e.g., amyloidosis).
  • Nonspecific ST-T wave changes (flattened/inverted T waves, QT prolongation) often correlate with diabetes, hypertension, or chronic kidney disease (CKD).

    • Clinical Context and Management:

  • Asymptomatic elderly patients with isolated first-degree AV block or nonspecific ST-T changes may require serial ECGs and risk factor modification (e.g., blood pressure control, glycemic management).
  • Symptomatic patients (e.g., dizziness, syncope, or heart failure) necessitate Holter monitoring, echocardiogram, or electrophysiological study (EPS) to assess for high-degree AV block or malignant arrhythmias.
  • Case Example:
    • An 80-year-old diabetic patient with hypertension and CKD presents with a PR interval of 240 ms and nonspecific ST depression in V4–V6. Given the absence of symptoms, the findings are attributed to age-related fibrosis. However, if the patient develops exertional dyspnea, an echocardiogram is performed, revealing diastolic dysfunction, prompting optimization of diuretics and rate control.

    Borderline QRS Voltages in Pediatric and Adolescent Patients

    Children and adolescents may exhibit borderline low QRS voltages (≤5 mm in limb leads or ≤10 mm in precordial leads) due to normal developmental changes, thin chest wall, or congenital heart disease. Differentiating physiological variants from pathological conditions (e.g., pericardial effusion, cardiomyopathies) requires careful assessment of growth parameters, family history, and associated symptoms.

    Key Considerations:

  • Normal variants in infants and young children include rightward axis deviation (due to thin chest walls) and incomplete RBBB (common in the first decade).
  • Pathological low voltages may indicate pericardial disease, infiltrative cardiomyopathies (e.g., Pompe disease), or severe pulmonary hypertension.
  • Case Example:
    • A 14-year-old girl with no past medical history presents with QRS amplitude of 3 mm in limb leads and 8 mm in V5–V6. Given her normal growth trajectory, absence of symptoms, and normal echocardiogram, the findings are classified as developmental variant. However, if she later develops exertional fatigue and hepatomegaly, genetic testing for lysosomal storage disorders is indicated.

    Comparative Analysis of Borderline ECG Prevalence and Significance

    The prevalence and clinical significance of borderline ECG findings vary across age, gender, and comorbidities. Below is a comparative table summarizing key differences:
    Parameter Athletes (18–35 years) Elderly (≥65 years) Pediatric/Adolescent (0–18 years)
    Prevalence of Borderline Findings
    • Early repolarization: 5–10% (higher in endurance athletes).
    • J-wave syndromes: 1–2% (associated with SCD risk in symptomatic cases).
    • Incomplete BBB: 10–15% (often benign).
    • First-degree AV block: Up to 20% (increases with age).
    • LBBB/RBBB: 5–10% (higher in hypertensive/ischemic patients).
    • Nonspecific ST-T changes: 20–30% (common in diabetes/CKD).
    • Low QRS voltages: 5–15% (higher in premature infants).
    • Incomplete RBBB: 10–20% (common in first decade).
    • Right axis deviation: 15–25% (normal in early childhood).
    Clinical Significance
    • ER variants: Low risk if asymptomatic (SCD risk <0.1%/year).
    • J-wave syndromes: High risk if symptomatic (requires ICD in high-risk cases).
    • Incomplete BBB: Generally benign unless associated with symptoms.
    • First-degree AV block: Monitor for progression (5% risk of high-degree block over 5 years).
    • LBBB/RBBB: Associated with CAD/heart failure (requires risk stratification).
    • Nonspecific ST-T changes: Correlate with diabetes/ischemia (higher CV risk).
    • Low QRS voltages: Pathological if <5 mm in limbs (evaluate for pericardial/cardiomyopathy).
    • Incomplete RBBB: Benign unless with structural heart disease.
    • Right axis deviation

      what is borderline ecg - Ilustrasi 3

      Advanced Tools and Technologies for Clarifying Borderline ECG Findings

      Digital signal processing (DSP) and artificial intelligence (AI) have transformed the interpretation of borderline ECG findings by enhancing pattern recognition, reducing interobserver variability, and automating initial triage. These technologies leverage machine learning algorithms trained on vast datasets to identify subtle deviations in waveforms, intervals, and morphologies that may escape human detection. While static ECGs provide a snapshot of cardiac electrical activity, borderline patterns often require dynamic assessment or multimodal integration to distinguish benign variants from clinically significant abnormalities.

      Digital Signal Processing and Automated ECG Analysis Algorithms

      Automated ECG analysis systems employ DSP techniques to preprocess raw signals, filter noise, and extract high-resolution features for algorithmic evaluation. Key applications include:
    • Waveform Enhancement: Techniques such as wavelet transforms and adaptive filtering improve signal-to-noise ratios, enabling clearer visualization of borderline ST-segment depressions or T-wave inversions.
    • Machine Learning Classification: Deep learning models (e.g., convolutional neural networks) analyze ECG traces to flag borderline findings with higher sensitivity than traditional criteria (e.g., Minnesota Code). For example, algorithms trained on datasets like the PhysioNet/Computing in Cardiology Challenge demonstrate >90% accuracy in identifying early ischemic changes.
    • Reduction of Human Error: Studies in emergency departments show that AI-assisted systems reduce misinterpretation rates of borderline ST-elevation by up to 40% compared to unaided cardiologists, particularly in low-prevalence settings where false-negative rates are critical.
      • Clinical Impact: Automated systems prioritize borderline ECGs for expert review, ensuring timely escalation without overwhelming clinicians with false positives.

      Advanced Imaging Modalities for Diagnostic Clarification

      Borderline ECG findings often warrant further evaluation with imaging to differentiate between structural and functional cardiac abnormalities. Key modalities include:

      - Cardiac Magnetic Resonance Imaging (MRI)

    • Role: Assesses myocardial tissue characterization (e.g., late gadolinium enhancement) to detect early fibrosis or infiltrative diseases (e.g., amyloid cardiomyopathy) in patients with nonspecific T-wave abnormalities.
    • Example: A patient with borderline T-wave inversions in V1–V4 may undergo MRI to rule out arrhythmogenic right ventricular dysplasia (ARVD), where characteristic fatty infiltration is visible even when ECG changes are subtle.
    • Limitations: Contraindications (e.g., pacemakers, claustrophobia) and cost restrict widespread use in acute settings.

      • - Nuclear Stress Testing (e.g., SPECT, PET)

    • Role: Evaluates myocardial perfusion defects in patients with borderline ST-T changes or nonspecific repolarization abnormalities, particularly in intermediate-risk coronary artery disease (CAD) populations.
    • Example: A 55-year-old with mild ST depression during exercise may undergo adenosine stress SPECT to quantify reversible perfusion deficits, guiding revascularization decisions.
    • Limitations: Radiation exposure and lower spatial resolution compared to MRI limit its use in low-prevalence scenarios.

      • - Echocardiography with Strain Imaging

    • Role: Detects subtle systolic dysfunction (e.g., global longitudinal strain < −18%) in patients with borderline left ventricular hypertrophy (LVH) or mild wall motion abnormalities.
    • Example: A patient with borderline voltage criteria for LVH on ECG may have normal ejection fraction but reduced strain, indicating early cardiomyopathy.
      • Integration Strategy: A stepwise approach—ECG → echocardiography → advanced imaging—optimizes diagnostic yield while minimizing unnecessary tests.

      Wearable ECG Devices and Dynamic Monitoring

      Wearable devices (e.g., Apple Watch, KardiaMobile) enable continuous or on-demand ECG recording, capturing transient or paroxysmal borderline changes that static 12-lead ECGs miss. Key applications include:

      - Detection of Paroxysmal Abnormalities

    • Example: A patient with intermittent ST-segment elevation during exertion may be diagnosed with vasospastic angina only after prolonged monitoring with a wearable device, whereas a single ECG might show normal findings.
    • Limitations: False positives occur in up to 30% of cases due to motion artifacts or benign variants (e.g., early repolarization in athletes).

      • - Atrial Fibrillation Screening

    • Role: Devices like the Apple Watch detect irregular rhythms with 98% sensitivity for AF episodes ≥30 seconds, though borderline cases (e.g., short runs of AF) may require confirmation with a 12-lead ECG.
    • Clinical Use Case: A patient with borderline P-wave abnormalities on ECG but no symptoms may be monitored for silent AF, reducing stroke risk.

      • - Exercise-Induced Changes

    • Example: KardiaMobile during treadmill testing can reveal dynamic ST depression in patients with microvascular angina, where resting ECGs are normal.
      • Validation Requirement: All wearable-detected borderline findings must be confirmed with a standard 12-lead ECG or Holter monitor to avoid overtreatment.

      Emerging Technologies and Future Directions

      The following innovations are redefining the classification of borderline ECG findings by improving specificity and reducing diagnostic uncertainty:

      - AI-Assisted ECG Interpretation

    • Examples:
    • ECG6000 Plus (GE Healthcare): Uses AI to classify borderline ST-segment deviations as ischemic or benign with 95% accuracy in validation studies.
    • Cardiologs (Israel): Combines ECG with clinical data to risk-stratify patients with borderline findings, reducing unnecessary hospitalizations by 25%.
    • Mechanism: Algorithms integrate temporal trends (e.g., serial ECGs) and patient-specific factors (e.g., comorbidities) to adjust diagnostic thresholds dynamically.

      • - High-Resolution ECG (HR-ECG)

    • Role: Captures microvolt-level ST-segment shifts and fragmented QRS complexes not visible on standard ECGs, improving detection of early myocardial injury.
    • Example: HR-ECG identified subclinical myocardial infarction in 12% of patients with borderline T-wave inversions in a study of post-COVID-19 patients.

      • - Multiparametric Wearable Systems

    • Integration: Combining ECG with photoplethysmography (PPG) and heart rate variability (HRV) data (e.g., BioIntelliSense) enhances detection of borderline autonomic dysfunction or early heart failure.
    • Example: A patient with borderline QTc prolongation may show abnormal HRV patterns, prompting further evaluation for long QT syndrome.

      • - Genomic and Biomarker Correlations

    • Example: Borderline Brugada-type ECG patterns in patients with SCN5A gene variants (linked to sudden cardiac death) may be reclassified as abnormal when combined with genetic testing.
      • Regulatory and Ethical Considerations: Emerging tools must undergo rigorous validation (e.g., FDA clearance for AI algorithms) to ensure clinical utility exceeds harm from false positives/negatives.

      Borderline ECG findings underscore the complexity of cardiac diagnostics, where subtle patterns demand a synthesis of clinical acumen, advanced tools, and patient-specific context. From distinguishing benign early repolarization in athletes to evaluating mild conduction delays in the elderly, the interpretation of these ambiguous results hinges on a systematic approach—one that balances the risks of overdiagnosis with the imperative of early detection. As digital health innovations, such as AI-assisted algorithms and wearable ECG devices, refine diagnostic precision, clinicians must adapt their workflows to leverage these advancements while maintaining a critical eye for false positives. Ultimately, borderline ECGs are not merely diagnostic challenges but opportunities to refine risk assessment, optimize patient management, and bridge the gap between uncertainty and actionable insights in cardiovascular care.

      FAQ

      What does it mean when an ECG is described as "borderline"?

      A "borderline" ECG typically means the results fall in an indeterminate range—neither clearly normal nor definitively abnormal—often seen in conditions like borderline sinus tachycardia, borderline ST-segment changes, or borderline axis deviation. It may require clinical correlation, repeat testing, or further evaluation (e.g., stress test) to determine significance. Common in early-stage abnormalities or non-specific findings.

      What does a borderline ECG on an EKG actually indicate?

      A borderline EKG suggests findings that might hint at an abnormality but lack definitive criteria (e.g., borderline ST elevation/depression, borderline Q waves, or borderline heart rate). It often prompts doctors to monitor symptoms, order additional tests (like troponin or echocardiogram), or reassess with a repeat EKG. The term implies uncertainty needing clinical judgment.

      What does borderline ECG sinus rhythm mean?

      Borderline sinus rhythm usually refers to a heart rate that is close to but not quite meeting criteria for tachycardia (e.g., 90–100 BPM instead of >100) or bradycardia (e.g., 50–59 BPM instead of <50). It may also describe sinus rhythm with subtle irregularities (like occasional pauses) that aren’t diagnostic of a clear arrhythmia. Often benign but warrants follow-up if symptoms (dizziness, fatigue) are present.

      What is the medical definition of a borderline ECG?

      In medical terms, a borderline ECG describes electrocardiographic findings that are at the threshold of abnormal criteria but don’t fully meet diagnostic standards (e.g., borderline left ventricular hypertrophy, borderline PR interval prolongation, or borderline QRS duration). It reflects a gray area where additional context (patient history, symptoms, or tests) is needed to rule in or out pathology.

      How is a borderline ECG interpreted in an ECG report?

      In an ECG report, "borderline" indicates findings that are questionable or non-diagnostic, such as:

      What does borderline ECG tracing refer to in medical practice?

      A borderline ECG tracing refers to graphical patterns that are at the limits of normal variation, such as:

      Leave a Comment

      Comments are moderated before appearing. The data you submit is processed according to the Privacy Policy of Voltefac.